Glenmede Trust’s Lemonade LMND Stock Holding History

Glenmede Trust’s Portfolio LMND Stock Details LMND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-6,136	Closed	-$571K	–	1300
2021 Q1	$571K	Buy	+6,136	New	+$793K	﹤0.01%	808

Other funds holding LMND

SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

GCGM

General Catalyst Group Management Cambridge, Massachusetts $189M AUM 10.96% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Zevenbergen Capital Investments Edmonds, Washington $4.37B AUM 52.9% 1-Year Est. Return

Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return

Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Glenmede Trust's LMND Position: Q2 2021 in Review

Glenmede Trust sold out of Lemonade (LMND) in Q2 2021, closing a stake of 6,136 shares — an estimated $571K sold.

Glenmede Trust first reported a position in LMND in Q1 2021 and held it in 1 quarter. The position peaked at $571K in Q1 2021. 315 funds tracked by Wall St. Rank hold LMND as of Q2 2021.

Glenmede Trust reported no remaining Lemonade position as of Q2 2021 after selling out during the quarter.
Glenmede Trust sold 6,136 Lemonade shares in Q2 2021, an estimated $571K.
Glenmede Trust first reported a position in Lemonade in Q1 2021 and held it in 1 quarter.
Glenmede Trust's Lemonade position peaked at $571K in Q1 2021.
315 funds tracked by Wall St. Rank held Lemonade as of Q2 2021.

Based on Glenmede Trust's 13F filing for Q2 2021, filed 16 Aug 2021.